Motoya Kitamura, previously managing partner of Japanese secondaries investor AB Value Capital Partners, has joined HQ Capital as a managing director.
Based in Hong Kong and Tokyo, Kitamura will join the firm’s Asia investment team, with a special focus on Japan. Prior to joining AB Value – formerly Ant Capital Partners – in 2018, he spent more...
Insilico Medicine, which leverages artificial intelligence (AI) technology to speed up the drug development process, has closed a $255 million Series C funding round led by Warburg Pincus.
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
PE-backed Abbisko Therapeutics, which focuses on the discovery and development of innovative and differentiated small molecule oncology therapies, has filed for a Hong Kong IPO.